Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
12 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to PolyPid Ltd.’s names, not what it holds today.
Patents granted
12
12 utility, 1976 to Dec 31, 2025
Granted in 2025
none
Against 1 in 2024 and none in 2023
Applications published
18
since 2001, to Dec 31, 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
'11'12'14'15'16'17'18'19'20'22'24
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
POLYPID LTD. its own name
IL, as the owner printed on each patent
3 publishedPOLYPID LTD. its own name
named as the applicant on its applications, in IL
15 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 7, 2024 | 11,975,101 | Compositions and methods for the treatment and prophylaxis of surgical site infections | Pharmaceuticals | POLYPID LTD. |
| Oct 18, 2022 | 11,471,414 | Compositions and methods for the treatment and prophylaxis of surgical site infections | Pharmaceuticals | POLYPID LTD. |
| Sep 1, 2020 | 10,758,639 | Methods for the treatment of peri-implantitis | Pharmaceuticals | POLYPID LTD. |
| Jun 16, 2020 | 10,682,412 | Sustained-release drug carrier composition | Pharmaceuticals | POLYPID LTD. |
| Nov 5, 2019 | 10,463,617 | Sustained-release drug carrier composition | Pharmaceuticals | POLYPID LTD. |
| Oct 23, 2018 | 10,105,443 | Sustained-release drug carrier composition | Pharmaceuticals | POLYPID LTD. |
| Apr 11, 2017 | 9,616,032 | Sustained-release nucleic acid matrix compositions | Pharmaceuticals | POLYPID LTD. |
| Aug 23, 2016 | 9,421,271 | Sustained-release drug carrier composition | Pharmaceuticals | POLYPID LTD. |
| Nov 3, 2015 | 9,173,976 | Compositions and methods for the treatment of bone voids and open fractures | Pharmaceuticals | POLYPID LTD. |
| Mar 31, 2015 | 8,992,979 | Sustained-release drug carrier composition | Pharmaceuticals | POLYPID LTD. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Jul 25, 2024 | 2024/0245608 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS | Pharmaceuticals | POLYPID LTD. |
| Feb 15, 2024 | 2024/0050396 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF SOLID TUMORS | Pharmaceuticals | POLYPID LTD. |
| Dec 15, 2022 | 2022/0395462 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS | Pharmaceuticals | POLYPID LTD. · patent 11,975,101 granted from it |
| Sep 17, 2020 | 2020/0289651 | SUSTAINED-RELEASE DRUG CARRIER COMPOSITION | Pharmaceuticals | POLYPID LTD. |
| Aug 27, 2020 | 2020/0268669 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS | Pharmaceuticals | POLYPID LTD. · patent 11,471,414 granted from it |
| Mar 7, 2019 | 2019/0070298 | SUSTAINED-RELEASE DRUG CARRIER COMPOSITION | Pharmaceuticals | POLYPID LTD. · patent 10,682,412 granted from it |
| Aug 31, 2017 | 2017/0246342 | METHODS FOR THE TREATMENT OF PERI-IMPLANTITIS | Pharmaceuticals | POLYPID LTD. · patent 10,758,639 granted from it |
| Aug 31, 2017 | 2017/0246112 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS | Pharmaceuticals | POLYPID LTD. |
| Dec 8, 2016 | 2016/0354470 | SUSTAINED-RELEASE DRUG CARRIER COMPOSITION | Pharmaceuticals | POLYPID LTD. · patent 10,105,443 granted from it |
| Jul 23, 2015 | 2015/0202349 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BONE VOIDS AND OPEN FRACTURES | Pharmaceuticals | POLYPID LTD. · patent 9,173,976 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 2.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.